🔗 Permalink

Inventor profile of:

Michael AVEN

City:

Mainz

Country:

Germany

Published Applications:

Last publication date:

2025-09-25

Top Assignees for applications by Michael AVEN

The entities that hold a legal rights for patent applications filed by inventor AVEN Michael:

BOEHRINGER INGELHEIM VETMEDICA GMBH 7 Ingelheim am Rhein, Germany
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 4 Ingelheim am Rhein, Germany
BASF AKTIENGESELLSCHAFT 3 Ludwigshafen, Germany
Boehringer Ingelheim Vetmedica GmbH 1 , Germany
BOEHRINGER INGELHEIM VETMEDICA GMBH 1 Ingelheim, Germany
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 1 Ingelheim, Germany

Recent patent applications by AVEN Michael

Michael AVEN from Mainz, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-25

US20250295787A1

Human necessities

PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION

#2 | 2024-01-25

US20240024482A1

Human necessities

PHARMACEUTICAL FORMULATION COMPRISING CICLESONIDE

#3 | 2022-02-10

US20220040313A1

Human necessities

PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION

#4 | 2021-04-15

US20210106685A1

Human necessities

Pharmaceutical formulation comprising ciclesonide

#5 | 2019-08-29

US20190262329A1

Human necessities

Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

#6 | 2018-11-29

US20180339054A1

Human necessities

Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition

#7 | 2018-06-07

US20180153907A1

Human necessities

Ciclesonide for the treatment of airway disease in horses

#8 | 2017-03-23

US20170079988A1

Human necessities

Ciclesonide for the treatment of airway disease in horses

#9 | 2017-01-12

US20170007593A1

Human necessities

Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

#10 | 2015-12-24

US20150366855A1

Human necessities

Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

#11 | 2015-11-05

US20150313918A1

Human necessities

Ciclesonide for the treatment of airway disease in horses

#12 | 2015-01-22

US20150025082A1

Human necessities

Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition

#13 | 2014-06-26

US20140179651A1

Human necessities

CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES

#14 | 2014-06-26

US20140179650A1

Human necessities

Pharmaceutical formulation comprising ciclesonide

#15 | 2012-03-08

US20120058980A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS

#16 | 2012-02-09

US20120035169A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA-AGONISTS

#17 | 2011-11-17

US20110281858A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS

#18 | 2010-12-30

US20100331288A1

Chemistry; metallurgy

CRYSTALLINE HYDRATE OF BETAMIMETIKA AND USE AS MEDICAMENT THEREOF

#19 | 2008-11-27

US20080293710A1

Human necessities

Aerosol formulation for the inhalation of beta-agonists

#20 | 2008-11-13

US20080280897A1

Human necessities

Aerosol Formulation for Inhalation

#21 | 2008-03-06

US20080053430A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS

#22 | 2008-02-21

US20080041370A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS

#23 | 2008-02-21

US20080041369A1

Human necessities

AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS

#24 | 2007-02-13

US10362058

Fungicidal formulation

#25 | 2005-11-17

US20050256115A1

Human necessities

Aerosol formulation for the inhalation of beta-agonists

#26 | 2005-05-17

US9865023

Enhancement of the activity of carotenoid biosynthesis inhibitor herbicides

#27 | 2005-03-29

US9491708

Non-aqueous emulsifiable concentrate formulation

InventorID:

816046 ⎘